OliX Pharmaceuticals, Inc (KOSDAQ:226950)
South Korea · Delayed Price · Currency is KRW
180,000
+20,600 (12.92%)
At close: Feb 27, 2026
Revenue by Segment
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 |
|---|
| 5.68B | 17.06B | 9.32B | 3.67B | 2.47B | | | |
| -66.73% | 83.09% | 153.66% | 48.50% | 118.90% | | | |
| 5.68B | 17.06B | 9.32B | 3.67B | 2.47B | | | |
| -66.73% | 83.09% | 153.66% | 48.50% | 118.90% | | | |
Source: S&P Global Market Intelligence.